研究者
J-GLOBAL ID:201901002596775002   更新日: 2022年12月20日

八巻 香織

ヤマキ カオリ | YAMAKI KAORI
論文 (19件):
  • Nobumichi Tanaka, Yasushi Nakai, Isao Asakawa, Kaori Yamaki, Makito Miyake, Shunta Hori, Takuya Owari, Tomomi Fujii, Kiyohide Fujimoto. Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy. International journal of urology : official journal of the Japanese Urological Association. 2022
  • Ryosuke Matsuda, Masatoshi Hasegawa, Tetsuro Tamamoto, Nobuyoshi Inooka, Mei Nikimoto, Tomoko Ochi, Toshiteru Miyasaka, Shigeto Hontsu, Kaori Yamaki, Sachiko Miura, et al. Long-Term Survival after Linac-Based Stereotactic Radiosurgery and Radiotherapy with a Micro-Multileaf Collimator for Brain Metastasis. Current oncology (Toronto, Ont.). 2022. 29. 9. 6068-6076
  • Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Yosuske Morizawa, Kaori Yamaki, Shunta Hori, Daisuke Gotoh, Makito Miyake, Kazumasa Torimoto, Masatoshi Hasegawa, et al. Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy. Brachytherapy. 2022. 21. 5. 626-634
  • Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Makito Miyake, Satoshi Anai, Kazumasa Torimoto, Kaori Yamaki, Tomomi Fujii, Masatoshi Hasegawa, Kiyohide Fujimoto. Mirabegron Reduces Urinary Frequency and Improves Overactive Bladder Symptoms at 3 Months After 125I-brachytherapy for Prostate Cancer: An Open-Labeled, Randomized, Non-Placebo-Controlled Study. Urology. 2022. 161. 87-92
  • Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Makito Miyake, Satoshi Anai, Kaori Yamaki, Masatoshi Hasegawa, Kiyohide Fujimoto. Erectile dysfunction and sexual quality of life in patients who underwent low-dose-rate brachytherapy alone for prostate cancer. Andrologia. 2022. 54. 1. e14288
もっと見る
MISC (17件):
もっと見る
経歴 (1件):
  • 2015/07 - 現在 奈良県立医科大学
所属学会 (3件):
日本癌治療学会 ,  日本放射線腫瘍学会 ,  日本医学放射線学会
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る